Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.
作者信息
Jones Ella F, Ray Kimberly M, Li Wen, Seo Youngho, Franc Benjamin L, Chien Amy J, Esserman Laura J, Pampaloni Miguel H, Joe Bonnie N, Hylton Nola M
机构信息
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA.
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA.
出版信息
Clin Breast Cancer. 2017 Jun;17(3):e155-e159. doi: 10.1016/j.clbc.2016.12.008. Epub 2016 Dec 29.
Abstract
摘要
相似文献
1
Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.专用乳腺正电子发射断层扫描用于评估乳腺癌新辅助化疗的早期反应
Clin Breast Cancer. 2017 Jun;17(3):e155-e159. doi: 10.1016/j.clbc.2016.12.008. Epub 2016 Dec 29.
2
Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.新辅助化疗后磁共振成像评估的完全缓解与病理肿瘤反应之间的差异因乳腺癌亚型而异。
Clin Breast Cancer. 2018 Apr;18(2):128-134. doi: 10.1016/j.clbc.2017.07.001. Epub 2017 Jul 21.
3
The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.乳腺癌对新辅助化疗反应的评估：磁共振成像与18F-氟脱氧葡萄糖正电子发射断层扫描的比较
Acta Radiol. 2011 Feb 1;52(1):21-8. doi: 10.1258/ar.2010.100142.
4
18 F-fluorodeoxyglucose uptake predicts pathological complete response after neoadjuvant chemotherapy for breast cancer: a retrospective cohort study.18F-氟代脱氧葡萄糖摄取预测乳腺癌新辅助化疗后的病理完全缓解：一项回顾性队列研究。
J Surg Oncol. 2013 Feb;107(2):180-7. doi: 10.1002/jso.23255. Epub 2012 Sep 4.
5
A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer.一例HER2非扩增型乳腺癌中S310F体细胞ERBB2突变的罕见病例
Clin Breast Cancer. 2017 Feb;17(1):e37-e41. doi: 10.1016/j.clbc.2016.08.001. Epub 2016 Aug 18.
6
Predicting pathological complete response in breast cancer early.早期预测乳腺癌的病理完全缓解
Lancet Oncol. 2014 Dec;15(13):1415-1416. doi: 10.1016/S1470-2045(14)71020-4. Epub 2014 Oct 30.
7
Predictive value of PET-CT for pathological response in stages II and III breast cancer patients following neoadjuvant chemotherapy with docetaxel.多西他赛新辅助化疗后PET-CT对II期和III期乳腺癌患者病理反应的预测价值
Rev Esp Med Nucl Imagen Mol. 2014 Jan-Feb;33(1):14-21. doi: 10.1016/j.remn.2013.04.008. Epub 2013 Jul 1.
8
Prediction of pathological response to neoadjuvant chemotherapy in breast cancer patients by imaging.通过影像学预测乳腺癌患者对新辅助化疗的病理反应
J Surg Res. 2018 May;225:175-180. doi: 10.1016/j.jss.2017.12.002. Epub 2018 Feb 21.
9
Breast cancer. Predicting nonresponders--light at the end of the PET tunnel.乳腺癌。预测无反应者——正电子发射断层显像检查困境中的一线曙光
Nat Rev Clin Oncol. 2015 Jan;12(1):2. doi: 10.1038/nrclinonc.2014.203. Epub 2014 Nov 18.
10
Clinicopathologic Factors Associated With Response to Neoadjuvant Anti-HER2-Directed Chemotherapy in HER2-Positive Breast Cancer.与曲妥珠单抗为基础的新辅助化疗治疗人表皮生长因子受体 2 阳性乳腺癌疗效相关的临床病理因素。
Clin Breast Cancer. 2020 Feb;20(1):19-24. doi: 10.1016/j.clbc.2019.09.003. Epub 2019 Sep 18.
引用本文的文献
1
Diagnostic performance of dedicated breast positron emission tomography.专用乳腺正电子发射断层扫描的诊断性能。
Breast Cancer. 2022 Nov;29(6):1013-1021. doi: 10.1007/s12282-022-01381-x. Epub 2022 Jun 29.
2
Development of High-Resolution Dedicated PET-Based Radiomics Machine Learning Model to Predict Axillary Lymph Node Status in Early-Stage Breast Cancer.基于高分辨率专用正电子发射断层扫描（PET）的影像组学机器学习模型用于预测早期乳腺癌腋窝淋巴结状态的研究进展
Cancers (Basel). 2022 Feb 14;14(4):950. doi: 10.3390/cancers14040950.
3
Terahertz Imaging for Breast Cancer Detection.太赫兹成像在乳腺癌检测中的应用。
Sensors (Basel). 2021 Sep 28;21(19):6465. doi: 10.3390/s21196465.
4
Evaluation of primary breast cancers using dedicated breast PET and whole-body PET.使用专用乳腺 PET 和全身 PET 对原发性乳腺癌进行评估。
Sci Rep. 2020 Dec 14;10(1):21930. doi: 10.1038/s41598-020-78865-3.
5
Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy.新辅助治疗的雌激素受体阳性乳腺癌的乳腺癌成像现状及反应的潜在定量成像标志物
Cancers (Basel). 2020 Jun 9;12(6):1511. doi: 10.3390/cancers12061511.
6
Kanakugiol, a Compound Isolated from , Promotes Cell Death by Inducing Mitotic Catastrophe after Cell Cycle Arrest.从[具体来源未给出]中分离出的化合物卡纳库吉醇（Kanakugiol），在细胞周期停滞后通过诱导有丝分裂灾难促进细胞死亡。
J Microbiol Biotechnol. 2020 Feb 28;30(2):279-286. doi: 10.4014/jmb.1909.09059.
7
Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.使用[F-18]氟雌二醇对雌激素受体阳性乳腺癌进行专用乳腺PET成像的初步经验。
NPJ Breast Cancer. 2019 Apr 16;5:12. doi: 10.1038/s41523-019-0107-9. eCollection 2019.
8
Microwave Sensors for Breast Cancer Detection.用于乳腺癌检测的微波传感器。
Sensors (Basel). 2018 Feb 23;18(2):655. doi: 10.3390/s18020655.
本文引用的文献
1
FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG-PET/CT）与磁共振成像（MRI）用于评估乳腺癌患者新辅助化疗后的病理反应：诊断准确性研究的荟萃分析
Oncologist. 2016 Aug;21(8):931-9. doi: 10.1634/theoncologist.2015-0353. Epub 2016 Jul 8.
2
Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CT.用于I-III期乳腺癌患者原发肿瘤可视化的悬吊式乳房PET系统评估：与标准PET/CT的比较
AJR Am J Roentgenol. 2016 Jun;206(6):1307-14. doi: 10.2214/AJR.15.15371. Epub 2016 Apr 8.
3
TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer.TBCRC 008研究：18F-FDG摄取在PET上的早期变化可预测人表皮生长因子受体2阴性原发性可手术乳腺癌术前全身治疗的反应
J Nucl Med. 2015 Jan;56(1):31-7. doi: 10.2967/jnumed.114.144741. Epub 2014 Dec 4.
4
Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy.¹⁸F-FDG PET/CT与MRI联合用于新辅助化疗期间乳腺癌的疗效监测
Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1515-24. doi: 10.1007/s00259-014-2770-2. Epub 2014 Apr 29.
5
Evaluating heterogeneity of primary tumor (18)F-FDG uptake in breast cancer with a dedicated breast PET (MAMMI): a feasibility study based on correlation with PET/CT.使用专用乳腺PET（MAMMI）评估乳腺癌原发肿瘤（18）F-FDG摄取的异质性：一项基于与PET/CT相关性的可行性研究。
Nucl Med Commun. 2014 May;35(5):446-52. doi: 10.1097/MNM.0000000000000072.
6
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.乳腺癌的病理完全缓解和长期临床获益：CTNeoBC 汇总分析。
Lancet. 2014 Jul 12;384(9938):164-72. doi: 10.1016/S0140-6736(13)62422-8. Epub 2014 Feb 14.
7
Triple-negative and non-triple-negative invasive breast cancer: association between MR and fluorine 18 fluorodeoxyglucose PET imaging.三阴性和非三阴性浸润性乳腺癌：MR 与氟 18 氟代脱氧葡萄糖 PET 成像的相关性。
Radiology. 2013 Nov;269(2):354-61. doi: 10.1148/radiol.13130058. Epub 2013 Jul 22.
8
Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: a meta-analysis.氟-18 氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描监测乳腺癌新辅助化疗反应的Meta 分析。
Clin Breast Cancer. 2013 Aug;13(4):271-9. doi: 10.1016/j.clbc.2013.02.003. Epub 2013 May 25.
9
Design and evaluation of the MAMMI dedicated breast PET.MAMMI 专用乳腺 PET 的设计与评估。
Med Phys. 2012 Sep;39(9):5393-404. doi: 10.1118/1.4742850.
10
Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET.乳腺癌的分子影像学：从全身 PET/CT 到专用乳腺 PET。
J Oncol. 2012;2012:438647. doi: 10.1155/2012/438647. Epub 2012 Jul 10.
Zotero 插件